+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

After the success of the previous edition - Bioprocessing of Advanced Cellular Therapies Congress 2016, MarketsandMarkets is pleased to announce the 2nd Annual Bioprocessing of Advanced Cellular Therapies Congress in London, UK.

Research Organizations and Pharma companies have been investing big time into the promise of cellular therapies and all signs point to the need to accelerate the process of moving from lab to patient using advanced manufacturing processes and solutions to commercialization.

With this objective, making the shift from manual processes to automation, bridging the gap between research lab and market place, and using novel and advanced technologies will be the key aspects for manufacturers to answer the challenge of scale-out.

The 2nd Annual Bioprocessing of Advanced Cellular Therapies Congress taking place on the 8th and 9th June, 2017 in London, UK focuses on this holistic approach by discussing the next generation bioprocessing, strategies, technologies and solutions to work together for this constantly evolving field.

conference Registration Form

-
 
  


Agenda

Key Highlights

Manuafacturing and Scale-up of Cellular Therapies

  • Novel technologies to manufacture Cell and Gene therapy
  • CAR-T Therapies
  • Cell Culture, assays and cell line development
  • Optimizing Cell Culture Media
  • Novel biomaterials technology to facilitate downstream processing
  • Gene Editing
  • Exosomes

 Next generation bioprocessing and in-line metrics

  • Online monitoring tools for bioprocessing
  • Organoid Culture
  • New systems – bioreactors and disposable technologies
  • Optimization and automation of processes
  • Inferential process control and implementation of PAT
  • Quality assurance and monitoring

Bioprocess Modelling, Commercialisation and Regulatory Issues

  • Business and process Modelling
  • Regulatory considerations
  • Overcoming challenges in Logistics and Supply Chain
For more information on the agenda of the conference, you can write to us at ajay.nimbalkar@marketsandmarkets.com

Who Should Attend ?

Industry Professionals

Engineers, scientists, academics and professionals working in 

  • Cell Culture
  • Cell Therapy
  • Upstream Processing
  • Biotechnology
  • Stem Cell therapy
  • Process Development
  • Bioprocessing
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Scale-up/out
  • Data management for cell-based products
  • Bioprocess development
  • Cellular Therapy
  • Gene Therapy
  • Therapeutics
  • Pharmacology
  • Quality Control
  • Biotherapeutics
  • Cell Engineering
  • Regulatory affairs

Academia: Universities and Research Institute 

Scientists/Professors/Researchers/Project leaders in

  • Cell therapy
  • Gene therapy
  • Cell culture
  • Cell Engineering
  • Bioprocessing
  • Biochemistry
  • Bioengineering
  • Biomaterials
  • Chemical Engineering
  • Molecular Biology
  • Material Sciences
  • Pharmacology
  • Biotechnology

Advisory Panel

  • Dr. Steve Oh
    Director, Stem Cell Bioprocessing
    BTI, Singapore
  • Dr. Damian Marshall
    Head of Analytical Development
    Ct Catapult, UK
  • Bo Kara
    Head Process Development, Cell & Gene Therapy Platform CMC
    GSK, UK
  • Dr. Otto-Wilhelm Merten
    ‎Head of the Applied Vectorology and Innovation group
    Généthon, France
  • Tiago Aguiar
    Process Development
    Autolus Ltd, UK

SPEAKERS

  • Dr. Ohad Karnieli

    CEO and Co-Founder, ATVIO Biotechnology, Israel
  • Prof. Timothy O'Brien

    Director of the Regenerative Medicine Institute, NUI, Galway and GUH, Ireland
  • Dr. Nina Kotsopoulou

    DPhil, Director, Process Development, Autolus, UK
  • Dr. Steve Oh

    Director, Stem Cell Bioprocessing, BTI, Singapore
  • Dr. Damian Marshall

    Head of Analytical Development, CT Catapult, UK
  • Dr. Takis Athanasopoulos

    Head of Transgene Delivery as part of the Cell & Gene Therapy Research & Development platform, GSK, UK
  • Dr. Andrea Ducci

    Senior Lecturer, Dept of Mechanical Engineering, Faculty of Engineering Science, UCL, UK
  • Dr. Nick Gaddum

    Lead Devices & Delivery Scientist, CT Catapult, UK
  • Dr. Ryan Guest

    Company Director and Director of Cell Production Cellular Therapeutics Limited, UK
  • Dr. David Brindley

    Senior Research Fellow in Healthcare Translation, University of Oxford, UK
  • Dr. Ivan Wall

    Senior Lecturer, Cell Therapy Bioprocessing, UCL, UK
  • Dawn Maier

    Associate Director- Cellular Process Development, Bluebird Bio, USA
  • Dr. Gabrielle Humphrey

    Technical Lead, MSAT Oxford BioMedica, United Kingdom
  • Prof. Mark W Lowdell

    Professor of Cell & Tissue Therapy Director of the Centre for Cell, Gene & Tissue Therapy Royal Free London NHS FT & UCL, United Kingdom
  • Dr. Manuel J T Carrondo

    Professor of Chemical and Biochemical Engineering, FCT-UNL Vice-President, IBET, Portugal
  • Prof. Daniel G. Bracewell

    Professor of Bioprocess Analysis & Doctoral Admissions Tutor Department of Biochemical Engineering UCL, United Kingdom
  • Kim Bure

    Director of Regenerative Medicine Sartorius Stedim Biotech, USA
  • Nick Timmins

    VP Technology CCRM, Toronto, Canada
  • Dr. Silke Wissing

    Director, R&D, CEVEC Pharmaceuticals GmbH, Germany
  • John Elliot

    Investigator, NIST, USA
  • Heather A. Beard

    Cell Production Manager, Cell Therapy, Advanced Therapies Facility Institute of Biomedical Research, University of Birmingham, UK
    

SPONSORS

Gold Sponsor


Bio-Rad

Bio-Rad Laboratories

Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for 60 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostic markets. Bio-Rad’s Life Science Group develops, manufactures, markets and supports a wide range of laboratory instruments, apparatus and consumables used for research in genomics, proteomics, cell biology and food safety.

In many of these areas, Bio-Rad is both a leading supplier and a pioneer. For example, in our efforts to advance the capabilities of PCR, Bio-Rad introduced the first commercially available droplet-based digital PCR platform; a system that has gone on to be cited in over 250 peer reviewed publications.

In cell biology, Bio-Rad has made life in the lab easier with the S3™ Cell Sorter and the new ZOE™ Fluorescent Cell Imager alongside an extensive range of performance guaranteed immunology antibodies.

For the study of proteins, Bio-Rad has a wide range of innovative chromatography, electrophoresis, western blotting and imaging systems as well as multiplex immunoassays are helping accelerate discovery and give greater confidence in results.

Bio-Rad operates globally with dedicated offices in over 75 countries, distributing, servicing and providing technical and customer support for over 10,000 products. For complete details of Bio-Rad's comprehensive range of products contact your local office or visit www.discover.bio-rad.com


Sponsors/Exhibitors



MacopharmaMacopharma’s Biotherapy division is specialised in providing GMP and Biobanking solutions to manufacturing, research labs, Biobanks and Hospitals, for cell therapy development and tissue engineering application.

We have therefore developed a closed system, xeno-free culture media and also a clinical grade human platelet lysate to culture cells to GMP standards, together with a whole range of disposables for stem cell collection, processing and expansion.


Eppendorf

Eppendorf 

Eppendorf 
is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling. By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player and valuable resource to its customers in the bioprocess marketplace.

Eppendorf was founded in Hamburg, Germany in 1945 and has more than 3,000 employees worldwide.


Cell GenixCellGenix
CellGenix is a premium supplier of high-quality GMP reagents and tools for cell and gene therapy and regenerative medicine applications. We offer a comprehensive product portfolio in combination with expert regulatory and technical support to ensure a seamless transition from research to commercialization. Our products combine a maximum of quality and safety due to state-of-the-art production, stringent in-house quality control and comprehensive documentation.


Markets and Markets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 

Exhibiting
All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

 

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings
Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support
Markets and Markets provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities, please contact Ajay Nimbalkar at ajay.nimbalkar@marketsandmarkets.com


Media partners

SUPPORTING ASSOCIATIONS

The United Kingdom Society for Biomaterials (UKSB)United Kingdom Society for Biomaterials (UKSB)

The United Kingdom Society for Biomaterials (UKSB) was set up to serve the diverse, interdisciplinary biomaterials research community. This was in response to the findings of a joint working party of the Institute of Materials and the Institute of Physics & Engineering in Medicine. The UKSB is the democratic Society for the whole biomaterials community.



Irish Stem Cell FoundationIrish Stem Cell Foundation

The Irish Stem Cell Foundation is an independent, non-profit medical research charity. Established in October 2009, it is composed of researchers, clinicians, patients advocates, patients, science communicators, bioethicists, lawyers, teachers, and students.



Global Institute of Stem Cell Therapy and Research (GIOSTAR)Global Institute of Stem Cell Therapy and Research (GIOSTAR)

GIOSTAR is a coalition of esteemed and illustrious scientific minds in the field of stem cell science, genetics and cancer research. GIOSTAR Chairman Dr. Anand Srivastva is credited for starting and establishing the field of stem cell science at the top universities of U.S.A. For over 15 years, GIOSTAR team of scientists and clinicians have been involved in the development and utilization of stem cell based clinical protocols related to stem cell transplants.


BioPharma Research CouncilBioPharma Research Council

The BioPharma Research Council is a nonprofit association for scientists, IT experts, entrepreneurs, and business professionals across all the many silos of biomedical research. Our mission is to foster collaboration and communication among professionals in industry, academia, nonprofit, government, and supplier labs in the biotech/biopharma space. Through conferences, symposia, webinars, Meetups, and committees, the BRC offers engaging in educational content to its community of more than 10,000 scientists, researchers, engineers, and industry experts each year. Many of these programs were suggested and developed through the energy and expertise of members of our community. Have an idea? Be in touch! info@biopharmaresearchcouncil.org

Swiss Biotech Association (SBA)

Swiss Biotech Association (SBA)

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ - the global brand for the industry.  

Since 2013, the academic network “biotechnet Switzerland” and the industry network “Swiss Biotech Association” together manage the “National Thematic Network (NTN) Swiss Biotech™” sponsored by the Swiss Commission for Technology & Innovation (CTI). NTN Swiss Biotech™ is a well-functioning network in Switzerland bringing together research institutions and industrial partners in life sciences. The network and its members are committed to collaborating with the CTI and its unique support services.

Venue

For more information on the venue of the conference, you can write to us at events@marketsandmarkets.com